Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bilastine pediatric pharmacokinetic study in allergic rhinoconjunctivitis or chronic urticaria
2009-012013-22Phase 2Completed
- Sponsor
- Faes Farma
- Start
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of bilastine in allergic rhinoconjunctivitis (ARC) and chronic urticaria (CU), sponsored by Faes Farma. Started Aug 2009; status: completed.
02
Drugs
bilastine
03
Conditions
allergic rhinoconjunctivitis (ARC)chronic urticaria (CU)
Beyond the preview
Go deeper on 2009-012013-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012013-22.